Balancing benefits and risks in the era of biologics

Adami, G., Saag, K.G., Chapurlat, R.D. et al. (7 more authors) (2019) Balancing benefits and risks in the era of biologics. Therapeutic Advances in Musculoskeletal Disease, 11. ISSN 1759-720X



  • Adami, G.
  • Saag, K.G.
  • Chapurlat, R.D.
  • Guañabens, N.
  • Haugeberg, G.
  • Lems, W.F.
  • Matijevic, R.
  • Peel, N.
  • Poddubnyy, D.
  • Geusens, P.
Copyright, Publisher and Additional Information: © The Author(s), 2019. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ( which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (
Keywords: benefit–risk ratio; biologics; denosumab; romosozumab
  • Accepted: 1 October 2019
  • Published (online): 24 October 2019
  • Published: 24 October 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 02 Dec 2019 16:10
Last Modified: 02 Dec 2019 16:16
Status: Published
Publisher: SAGE Publications
Refereed: Yes
Identification Number:
Related URLs: